Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsBasile Njei, MD, PhD, FRCP
Assistant Professor AdjunctAbout
Research
Publications
2026
Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Diarrhoeal Disease and Enteric Infectious Diseases Collaborators. Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Infect Dis 2026 PMID: 42229499, DOI: 10.1016/S1473-3099(26)00194-5.Peer-Reviewed Original ResearchEffect of coded steatotic liver disease on outcomes of percutaneous coronary intervention in non-diabetic adults: insights from a multicenter real-world cohort.
Issaka Y, Maraqah M, Meyahnwi D, Adjei-Sefah K, Okorigba E, Oparah M, Boateng S, Abdul-Kareem H, Adefuye M, Nguefang GL, Njei B, Hahn S, Zarich S. Effect of coded steatotic liver disease on outcomes of percutaneous coronary intervention in non-diabetic adults: insights from a multicenter real-world cohort. BMC Cardiovasc Disord 2026 PMID: 42185950, DOI: 10.1186/s12872-026-06017-y.Peer-Reviewed Original ResearchAn Explainable AI Tool (FibroX) for Detecting Advanced Liver Fibrosis in Adults With Type 2 Diabetes: Protocol for a Pilot Crossover Trial.
Njei B, Kanmounye US. An Explainable AI Tool (FibroX) for Detecting Advanced Liver Fibrosis in Adults With Type 2 Diabetes: Protocol for a Pilot Crossover Trial. JMIR Res Protoc 2026, 15: e90456. PMID: 41974444, DOI: 10.2196/90456.Peer-Reviewed Original ResearchLarge Language Models for Diagnosis and Prognosis of Chronic Liver Diseases: A Systematic Review.
Njei B, Al-Ajlouni YA, Ajayi A, Shahin F, Ta'ani OA, Boateng S, Ketwaroo G, Protiva P. Large Language Models for Diagnosis and Prognosis of Chronic Liver Diseases: A Systematic Review. Health Sci Rep 2026, 9: e72476. PMID: 42089001, DOI: 10.1002/hsr2.72476.Peer-Reviewed Original ResearchA Multi-Phase Protocol for Developing and Validating an Explainable AI Framework for Continuous Monitoring, Risk Stratification, and Clinical Decision Support in Primary Biliary Cholangitis.
Njei B, Sidney Kanmounye U. A Multi-Phase Protocol for Developing and Validating an Explainable AI Framework for Continuous Monitoring, Risk Stratification, and Clinical Decision Support in Primary Biliary Cholangitis. JMIR Res Protoc 2026 PMID: 42184424, DOI: 10.2196/89279.Peer-Reviewed Original ResearchFibroAgent: An Agentic AI Tool for Liver Fibrosis Screening and Clinical Decision Support in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Njei B, Ali I, Al-Ajlouni Y, Boateng S, Nguefang GL, Ameyaw P, Kanmounye US, Njei N, Gyabaah S. FibroAgent: An Agentic AI Tool for Liver Fibrosis Screening and Clinical Decision Support in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Cureus 2026, 18: e106372. PMID: 42083670, DOI: 10.7759/cureus.106372.Peer-Reviewed Original ResearchOutcomes of GLP-1 receptor agonist therapy in adults with sickle cell disease and type 2 diabetes: a real-world cohort analysis.
Nguefang GL, Boateng S, Gyabaah S, Issaka Y, Konlack JG, Landa EL, Eze E, Njei B. Outcomes of GLP-1 receptor agonist therapy in adults with sickle cell disease and type 2 diabetes: a real-world cohort analysis. Orphanet J Rare Dis 2026, 21 PMID: 41904481, DOI: 10.1186/s13023-026-04322-5.Peer-Reviewed Original ResearchMetabolic dysfunction-associated steatotic liver disease increases the risk of acute kidney injury in septic shock: A United States population-based study.
Nguefang Tchoukeu GL, Boateng S, Issaka Y, Eze E, Al-Ajlouni YA, Ameyaw PA, Landa EL, Verma A, Kaur A, Mekontso JGK, Njei B. Metabolic dysfunction-associated steatotic liver disease increases the risk of acute kidney injury in septic shock: A United States population-based study. Medicine (Baltimore) 2026, 105: e48142. PMID: 41894287, DOI: 10.1097/MD.0000000000048142.Peer-Reviewed Original ResearchVisa restrictions: A structural determinant of global health that must be confronted head-on.
Bain LE, Ojong SA, Sindi JK, Njei B, Omam LA, Kyobutungi C. Visa restrictions: A structural determinant of global health that must be confronted head-on. PLOS Glob Public Health 2026, 6: e0006178. PMID: 41886414, DOI: 10.1371/journal.pgph.0006178.Commentaries, Editorials and LettersHealthcare access and barriers in Jordan: Insights from a Nationwide Survey
Al-Ajlouni Y, Ayyad M, Tanashat M, Al Ta’ani O, AlMomani H, Nusier J, Abouzid M, Nagi Y, Njei B. Healthcare access and barriers in Jordan: Insights from a Nationwide Survey. PLOS ONE 2026, 21: e0345456. PMID: 41875192, PMCID: PMC13012521, DOI: 10.1371/journal.pone.0345456.Peer-Reviewed Original ResearchConceptsHealthcare accessSpecialist careBarriers to healthcare accessSelf-reported health statusAssociated with healthcare accessFear of diagnosisHealthcare access disparitiesHealth-related factorsMiddle-income countriesNationwide surveyHealth integrationPublic health concernChi-square testRoutine check-upHealth statusAccess disparitiesMarried participantsMarital statusEmployment statusExcellent healthSocioeconomic factorsHealthcareHealthcare infrastructureFinancial constraintsRetired individuals
Academic Achievements & Community Involvement
News
News
- February 25, 2026
Njei to Visit Oxford via Sherlock Traveling Fellowship
- October 15, 2025
Welcome New Faculty and Postgrads in the Yale Department of Internal Medicine (October 2025)
- March 06, 2025
Meet Yale Internal Medicine: Basile Njei, MD, PhD, MPH
- December 03, 2024Source: MEDPAGETODAY
Lean MASH Patients Face Higher Mortality and Worse Outcomes
Get In Touch
Contacts
Email